ABSTRACT Seventy asthmatic patients newly referred to a hospital outpatient clinic have been studied. In one-third of the patients the diagnosis of asthma had not 
The 1960-65 epidemic increase in asthma deaths' has stimulated interest in the management of acute severe asthma. Nevertheless about 1500 patients continue to die from asthma each year in the UK;2 a similar number were dying in 1960 immediately before the epidemic began.' Thus a graph of asthma deaths now shows a plateau, uninfluenced by the use of selective ,B-sympathomimetic drugs, intensive care units, and self-admission units. The natural history of chronic asthma and its relationship to lifethreatening asthma is poorly documented. A recent study of the treatment of asthma in general practice has shown that symptomatic patients suffering from airways obstruction may 
Results
Seventy asthmatic patients (30 males and 40 females) aged 37 (± 15) years were included in the study. Asthma had not previously been diagnosed in 22 (31%) patients, who had been symptomatic for a mean of 3-8 (± 4 7) years. The remaining 48 patients were referred for reassessment and had a longer mean history of asthma (13-6 ± 12'3 years).
The episodic nature of the symptoms of cough, wheeze, and breathlessness made it impossible to grade the patients' dyspnoea with any degree of accuracy. The initial FEV1 ranged from 0-654-9 litres (23-132% predicted) in male and from being unrecordable to 3 9 litres (unrecordable-134% predicted) in female patients. The very low values measured in some patients are disguised by the mean presenting FEV1, which was 2-2 (± 1-0) litres or 71 (± 27)% predicted. Significant improvement in FEV1 followed stabilisation on an adjusted treatment regimen (p < 0-001). The mean stable FEV1 was 2-7 (± 0 85) litres, or 91 (± 21)% predicted. There was a 41-5 (± 62) % improvement in FEV1 which was similar in males and females (fig 1) . Several patients had evidence of severe airways obstruction. They were not suffering from "status asthmaticus" nor from "acute severe asthma".13 Both these terms attempt to define an acute and potentially fatal asthma attack. However, it is not unreasonable to postulate that these patients with symptoms of cough, wheeze, and breathlessness lasting several weeks, a low FEV1 and often a low Pao2 were in a critical phase of their disease.
Patterns of airflow obstruction in bronchial asthma may relate to pathogenesis.14 It has been suggested that they may be used to identify patients at high risk and that patients with gradually deteriorating airflow obstruction have an increased risk of sudden death from asthma. 15 The clinical categorisation of patients into those with acute and those with chronic symptoms neglects the severe functional impairment which may be present in the latter group. The diagnosis of bronchial asthma embraces a spectrum of disease processess. Identification of the pattern of airflow obstruction may not only lead to better patient management but also provide information about pathogenesis.
The symptom of dyspnoea has once again been shown to be an unreliable guide to the severity of asthma. The combination of a diagnosis of asthma' symptoms of cough, wheeze, and breathlessness with serial measurements of lung function should be used to alert the medical practitioner to a potentially critical situation. Neither "status asthmaticus" nor "acute severe asthma" necessarily precedes death from asthma.'3 Patients with chronic asthma may be equally at risk. Diagnosis and treatment of these patients is rewarding and may help to reduce the number of asthma deaths.
